Journal article

Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

O Johnell, WH Scheele, YL Lu, JY Reginster, AG Need, E Seeman

Journal of Clinical Endocrinology & Metabolism | ENDOCRINE SOC | Published : 2002

DOI: 10.1210/jc.87.3.985

University of Melbourne Researchers

Citation metrics

159Web of Science
195Scopus
170Dimensions

Keywords

Bisphosphonates
Middle Aged
Biomarkers
Alendronate
Raloxifene Hydrochloride
Endocrinology & Metabolism
Aged
Vertebral Fractures
Bone Density
Collagen
Microdamage Accumulation
Double-Blind Method
Risk
Humans
Selective Estrogen Receptor Modulators
Science & Technology
Mineral Density
Clinical-Trial
Lumbar Vertebrae
Bone Remodeling
Randomized Controlled Trial
Osteoporosis, Postmenopausal
Life Sciences & Biomedicine
Biological Markers
Femur Neck
Osteocalcin
Hormone Replacement Therapy
Drug Synergism
Raloxifene
Estrogen
Collagen Type I
Peptides
Turnover
Female